CUSIP: 00507W107
Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
14,188,770
-
Share change
-
+10,423,335
-
Total reported value
-
$8,157,000
-
Price per share
-
$0.57
-
Number of holders
-
29
-
Value change
-
+$5,972,907
-
Number of buys
-
14
-
Number of sells
-
7
Quarterly Holders Quick Answers
What is CUSIP 00507W107?
CUSIP 00507W107 identifies ATNM - ACTINIUM PHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2017
-
Previous quarter:
Q2 2017
Recent filing periods for CUSIP 00507W107:
Institutional Holders of ACTINIUM PHARMACEUTICALS INC - COM (ATNM) as of Q3 2017
As of 30 Sep 2017,
ACTINIUM PHARMACEUTICALS INC - COM (ATNM) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,188,770 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, SABBY MANAGEMENT, LLC, VANGUARD GROUP INC, Sio Capital Management, LLC, Anson Funds Management LP, CREDIT SUISSE AG/, BlackRock Inc., DAFNA Capital Management LLC, GEODE CAPITAL MANAGEMENT, LLC, and BRIDGEWAY CAPITAL MANAGEMENT INC.
This page lists
29
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.